Older studies can underestimate prognosis of glioblastoma biomarker in meta-analyses: a meta-epidemiological study for study-level effect in the current literature Victor M. LuKevin PhanKerrie L. McDonald Topic Review 16 May 2018 Pages: 231 - 238
Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors Anthony R. GuastellaSharon K. MichelhaughSandeep Mittal Laboratory Investigation 17 April 2018 Pages: 239 - 249
Association between programmed cell death ligand-1 expression and extracranial metastasis in intracranial solitary fibrous tumor/hemangiopericytoma Dai KamamotoKentaro OharaHikaru Sasaki Laboratory Investigation 19 April 2018 Pages: 251 - 259
IDH1 mutation in human glioma induces chemical alterations that are amenable to optical Raman spectroscopy Ortrud UckermannWenmin YaoMatthias Kirsch Laboratory Investigation 14 May 2018 Pages: 261 - 268
GOLPH3 promotes glioma progression via facilitating JAK2–STAT3 pathway activation Shishuang WuJiale FuXiuping Zhou Laboratory Investigation 30 April 2018 Pages: 269 - 279
PD-1/PD-L1 and immune-related gene expression pattern in pediatric malignant brain tumors: clinical correlation with survival data in Korean population Kihwan HwangEun Jung KohChae-Yong Kim Laboratory Investigation 05 May 2018 Pages: 281 - 291
Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery Adrienn VolakStanley G. LeRoyCasey A. Maguire Laboratory Investigation 16 May 2018 Pages: 293 - 305
Oligodendrogliomas in pediatric and teenage patients only rarely exhibit molecular markers and patients have excellent survivals Yan-Xi LiAbudumijiti AibaidulaHo-Keung Ng Laboratory Investigation 14 May 2018 Pages: 307 - 322
Down-regulation of MDR1 by Ad-DKK3 via Akt/NFκB pathways augments the anti-tumor effect of temozolomide in glioblastoma cells and a murine xenograft model Toshitaka FujiharaYoshifumi MizobuchiYasushi Takagi Laboratory Investigation 19 May 2018 Pages: 323 - 332
Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis Fu ZhaoJing ZhangPinan Liu Clinical Study 23 April 2018 Pages: 333 - 340
Cranial nerve outcomes after primary stereotactic radiosurgery for symptomatic skull base meningiomas Andrew FaramandHideyuki KanoL. Dade Lunsford Clinical Study 24 April 2018 Pages: 341 - 348
Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma Maarten M. J. WijnengaPim J. FrenchMartin J. van den Bent Clinical Study Open access 16 April 2018 Pages: 349 - 357
Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy Pim B. van der MeerEsther J. J. HabetsMartin J. B. Taphoorn Clinical Study Open access 16 April 2018 Pages: 359 - 368
Pazopanib efficacy in recurrent central nervous system hemangiopericytomas Caroline ApraAgusti AlentornMarc Sanson Clinical Study 26 April 2018 Pages: 369 - 372
Contrast enhancement predicting survival in integrated molecular subtypes of diffuse glioma: an observational cohort study Johann-Martin HempelCornelia BrendleJens Schittenhelm Clinical Study 17 April 2018 Pages: 373 - 381
Third-line therapy in recurrent glioblastoma: is it another chance for bevacizumab? Enrico FranceschiGiuseppe LambertiAlba A. Brandes Clinical Study 18 April 2018 Pages: 383 - 388
Management of glioblastoma at safety-net hospitals Michael G. BrandelRobert C. RennertAlexander A. Khalessi Clinical Study 24 April 2018 Pages: 389 - 397
18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study Chirag B. PatelElisa FazzariBenjamin M. Ellingson Clinical Study 20 April 2018 Pages: 399 - 409
Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide Erkan TopkanUgur SelekKadir Tufan Clinical Study 25 April 2018 Pages: 411 - 419
Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicity Kevin DiaoShelly X. BianEric L. Chang Clinical Study 25 April 2018 Pages: 421 - 429
MR-spectroscopic imaging of glial tumors in the spotlight of the 2016 WHO classification Elie DiamandisCarl Phillip Simon GabrielDieter Henrik Heiland Clinical Study 27 April 2018 Pages: 431 - 440
The influence of preoperative dependency on mortality, functional recovery and complications after microsurgical resection of intracranial tumors Martin N. StienenDavid Y. ZhangLuca Regli Clinical Study 02 May 2018 Pages: 441 - 448
Postoperative hypofractionated stereotactic brain radiation (HSRT) for resected brain metastases: improved local control with higher BED10 Aryavarta M. S. KumarJonathan MillerMitchell Machtay Clinical Study 10 May 2018 Pages: 449 - 454
Prediction of survival in patients affected by glioblastoma: histogram analysis of perfusion MRI Andrea RomanoLuca PasquiniAlessandro Bozzao Clinical Study 02 May 2018 Pages: 455 - 460
Initial brain metastasis velocity: does the rate at which cancers first seed the brain affect outcomes? Michael H. SoikeEmory R. McTyreMichael D. Chan Clinical Study 08 May 2018 Pages: 461 - 467
Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design Richard G. EversonYuuri HashimotoShaan M. Raza Clinical Study 30 May 2018 Pages: 469 - 478
Treatment and survival of glioblastoma patients in Denmark: The Danish Neuro-Oncology Registry 2009–2014 Steinbjørn HansenBirthe Krogh RasmussenKim Oren Gradel Clinical Study 12 May 2018 Pages: 479 - 489
Machine learning: a useful radiological adjunct in determination of a newly diagnosed glioma’s grade and IDH status Céline De LoozeAlan BeausangHugh Kearney Clinical Study 16 May 2018 Pages: 491 - 499
Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients? Geert O. JanssensChristof M. KrammAndre O. von Bueren Letter to the Editor 17 April 2018 Pages: 501 - 501
Leptomeningeal disease in uveal melanoma: a case series Isabella C. GlitzaSujan T. ReddySapna P. Patel Letter to the Editor 27 April 2018 Pages: 503 - 505